MMRd tumours are then tested further to eliminate those where instability is somatic in origin, before screening for germline pathogenic MMR variants (https://www.nice.org.uk/guidance/dg27/resources/testing-strategies-flowchart-pdf-4367005453 accessed on 30 May 2022). The gene discussed is MRC1; the disease is neoplasm.